清肺口服液治疗小儿病毒性肺炎痰热闭肺证507例临床研究  

Clinical Study on Qingfei Oral Liquid Treating 507 Cases of Phlegm-heat Obstructing Lung Syndrome in Children Virus Pneumonia

作　　者：汪受传[1] 孙轶秋[1] 卞国本 徐玲 马融[4] 王孟清[5] 刘光陵[6] 

机构地区：[1]南京中医药大学附属医院,南京210029 [2]常州市中医院,常州213003 [3]盐城市中医院,盐城224002 [4]天津中医药大学第一附属医院,天津300193 [5]湖南中医药大学附属第一医院,长沙410007 [6]南京军区总医院,南京210002

出　　处：《世界中医药》2016年第9期1649-1653,1658,共6页World Chinese Medicine

基　　金：江苏省社会发展计划项目(编号:BS96052);"十五"国家科技攻关计划项目(编号:2001BA701A16b)

摘　　要：目的:观察清肺口服液治疗小儿病毒性肺炎痰热闭肺证的有效性、安全性。方法:以利巴韦林注射液为对照,采用清肺口服液治疗小儿病毒性肺炎痰热闭肺证,进行了两期6中心的507例随机对照临床试验。结果:两期临床研究的结果均表明:清肺口服液临床疗效显著优于利巴韦林注射液(P<0.05):清肺口服液和利巴韦林注射液均未见明显的临床不良反应。结论:清肺口服液是治疗小儿病毒性肺炎痰热闭肺证有效而安全的药物。Objective： To study the effectiveness and safety of Qingfei Oral Liquid for phlegm-heat obstructing lung syndrome in children virus pneumonia. Methods： A total of 507 cases of phlegm-heat obstructing lung syndrome in children virus pneumonia were studied in two-stage and six-center randomized controlled clinical trials. Qingfei oral liquid was used in treat group,while ribavirin injection was used in control group. Results： Two-stage clinical trials showed that the effect of Qingfei Oral Liquid was significantly better than that of ribavirin injection（ P〈0. 05）. Conclusion： Qingfei Oral Liquid is effective and safe in treating phlegmheat obstructing lung syndrome in children virus pneumonia.

关 键 词：清肺口服液 小儿病毒性肺炎 痰热闭肺证 临床研究 

分 类 号：R272[医药卫生—中医儿科学]